{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:36:27Z","timestamp":1792636587350,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005699","name":"Universit\u00e0 degli Studi del Piemonte Orientale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006282","name":"Koning Boudewijnstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bioflm.2023.100106","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T02:26:58Z","timestamp":1675650418000},"page":"100106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium"],"prefix":"10.1016","volume":"5","author":[{"given":"Amber","family":"De Bleeckere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Van den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter-Jan","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Beirens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Crabb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-0601","authenticated-orcid":false,"given":"Tom","family":"Coenye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bioflm.2023.100106_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009589","article-title":"CFTR, mucins, and mucus obstruction in cystic fibrosis","volume":"2","author":"Kreda","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100106_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9100234","article-title":"Adapting to the airways: metabolic requirements of Pseudomonas aeruginosa during the infection of cystic fibrosis patients","volume":"9","author":"la Rosa","year":"2019","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100106_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100106_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tim.2013.06.002","article-title":"The in vivo biofilm","volume":"21","author":"Bjarnsholt","year":"2013","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bioflm.2023.100106_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00913","article-title":"Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents - how P. aeruginosa Can escape antibiotics","volume":"10","author":"Ciofu","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bioflm.2023.100106_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-022-00682-4","article-title":"Tolerance and resistance of microbial biofilms","author":"Ciofu","year":"2022","journal-title":"Nature Reviews Microbiology. Nature Research"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100106_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tim.2014.02.001","article-title":"Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms","volume":"22","author":"van Acker","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bioflm.2023.100106_bib8","first-page":"141","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"vol. 19","author":"Leclercq","year":"2013"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100106_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/dkg312","article-title":"European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria","volume":"52","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100106_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/1469-0691.12373","article-title":"Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories","volume":"20","author":"Matuschek","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"161","key":"10.1016\/j.bioflm.2023.100106_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0055-2021","article-title":"The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects","volume":"30","author":"van den Bossche","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100106_bib12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.tim.2019.05.003","article-title":"Antimicrobial tolerance and metabolic adaptations in microbial biofilms","volume":"27","author":"Crabb\u00e9","year":"2019","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.bioflm.2023.100106_bib13","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/S1473-3099(21)00122-5","article-title":"The importance of understanding the infectious microenvironment","volume":"22","author":"Bjarnsholt","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"10.1016\/j.bioflm.2023.100106_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1717525115","article-title":"Pseudomonas aeruginosa transcriptome during human infection","volume":"115","author":"Cornforth","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100106_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05944-5","article-title":"High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs","volume":"9","author":"Rossi","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100106_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11414-3","article-title":"Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung","volume":"10","author":"Kordes","year":"2019","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.bioflm.2023.100106_bib17","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/JB.01138-07","article-title":"Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum","volume":"189","author":"Palmer","year":"2007","journal-title":"J Bacteriol"},{"issue":"13","key":"10.1016\/j.bioflm.2023.100106_bib18","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1073\/pnas.1419677112","article-title":"Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum","volume":"112","author":"Turner","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100106_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.03042-19","article-title":"Quantitative framework for model evaluation in microbiology research using Pseudomonas aeruginosa and cystic fibrosis infection as a test case","volume":"11","author":"Cornforth","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.bioflm.2023.100106_bib20","first-page":"981","article-title":"Antimicrobial susceptibility testing in biofilm-growing bacteria","volume":"vol. 20","author":"Maci\u00e0","year":"2014"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100106_bib21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mbo3.141","article-title":"Developing an international Pseudomonas aeruginosa reference panel","volume":"2","author":"de Soyza","year":"2013","journal-title":"Microbiologyopen"},{"issue":"14","key":"10.1016\/j.bioflm.2023.100106_bib22","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1073\/pnas.0832438100","article-title":"Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa","volume":"100","author":"Wolfgang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bioflm.2023.100106_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/8756479308317006","article-title":"Measures of association: how to choose?","volume":"24","author":"Khamis","year":"2008","journal-title":"J Diagn Med Sonogr"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100106_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0013164493053001007","article-title":"Table for conversion of kendall\u2019s tau to spearman\u2019s rho within the context of measures of magnitude of effect for meta-analysis","volume":"53","author":"Gilpin","year":"1993","journal-title":"Educ Psychol Meas"},{"key":"10.1016\/j.bioflm.2023.100106_bib25","first-page":"1","article-title":"Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung","volume":"64","author":"Kirchner","year":"2012","journal-title":"JoVE"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100106_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02204-19","article-title":"Activity of antibiotics against Pseudomonas aeruginosa in an in vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium","volume":"64","author":"Diaz Iglesias","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100106_bib27","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jac\/dkab068","article-title":"A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms","volume":"76","author":"Frisch","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.bioflm.2023.100106_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9120880","article-title":"Antimicrobial susceptibility testing in pseudomonas aeruginosa biofilms: one step closer to a standardized method","volume":"9","author":"Lozano","year":"2020","journal-title":"Antibiotics"},{"issue":"12","key":"10.1016\/j.bioflm.2023.100106_bib29","first-page":"1171","article-title":"Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill pseudomonas aeruginosa","volume":"166","author":"Sweeney","year":"2020","journal-title":"Microbiology (United Kingdom)"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100106_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1099\/jmm.0.45969-0","article-title":"Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung","volume":"54","author":"Sriramulu","year":"2005","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100106_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006842","article-title":"Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments","volume":"14","author":"Pestrak","year":"2018","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100106_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ppul.21350","article-title":"Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection","volume":"46","author":"Moskowitz","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100106_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcf.2014.09.013","article-title":"Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients","volume":"14","author":"Yau","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100106_bib34","article-title":"Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis","volume":"2020","author":"Smith","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100106_bib35","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/JCM.42.5.1915-1922.2004","article-title":"Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis","volume":"42","author":"Moskowitz","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bioflm.2023.100106_bib36","series-title":"The structure\u2013function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment","author":"Lichtenberg","year":"2022"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100106_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac082","article-title":"Establishing antimicrobial susceptibility testing methods and clinical breakpoints for inhaled antibiotic therapy","volume":"9","author":"Ekkelenkamp","year":"2022","journal-title":"Open Forum Infect Dis"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207523000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207523000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:57:58Z","timestamp":1762919878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207523000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":37,"alternative-id":["S2590207523000035"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2023.100106","relation":{},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2023.100106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100106"}}